The stocks of BAC have already received a rating of buy from around twenty-two different analysts. In a report, one of the investment analysts has prescribed the stocks with a rating of sell, while five others have issued the company with a rating of hold. Fifteen others have given the company a rating of buy. Currently, the price target of the company over a period of a year has been $40.14.
The Stock Commentary Of BAC
There have been quite a few research equities that have commented on the stocks of BAC. Zacks Investment Research has already increased the rating of the company from hold to buy with a price target of $42 in an 18th June research report. Robert W. Baird has already put up a rating of neutral with a price target of $42 in a 10th May research report.
Deutsche Bank has already increased the price target of the company from $35 to $44 with a rating of buy in a 1st April research report. Truist has also put up a rating of buy in a 2nd June research report. In the end, Evercore ISI has decided to put up a rating of buy with a $43 price target in a 2nd July research report.
The stocks of BAC traded on Friday at $38.83. The moving average price of the company over a period of 50 days has been $41.47. The market cap of the firm is $332.75 billion, a PE ratio of 16.67, a 1.84 PEG ratio, and a 1.54 beta. The year low of the company over the period of a year has been $22.95, with a year high of $43.49. The current ratio of the company is 0.76, with a 0.76 quick ratio.
BAC previously announced its quarterly earnings on the 14th of July. The EPS reported by the company during this period was $1.03, which was more than the consensus estimate of $0.77. The revenue generated by the company during this period was $21.50 billion, which was slightly less than the consensus estimate of $21.77 billion. The net margin of the company has been 24.09%, with an 8.90% return on equity.